Douglas E. Giordano

Insider Reports History

Location
New York, NY
Signature
/s/ Mark Bodenrader, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Douglas E. Giordano:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cerevel Therapeutics Holdings, Inc. Director Common Stock 0 $0 $41.18 01 Aug 2024 Direct
Cerevel Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 0 01 Aug 2024 Direct

Insider Reports Filed by Douglas E. Giordano

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000095017024090853-giordano-douglas-e-2024-08-01 Cerevel Therapeutics Holdings, Inc. 01 Aug 2024 3 $0 4 Director 05 Aug 2024, 16:36
/report/000095017024070724-giordano-douglas-e-2024-06-05 Cerevel Therapeutics Holdings, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:30
/report/000089924323015181-giordano-douglas-e-2023-06-07 Cerevel Therapeutics Holdings, Inc. 07 Jun 2023 2 $0 4 Director 09 Jun 2023, 16:15
/report/000089924322022833-giordano-douglas-e-2022-06-14 Cerevel Therapeutics Holdings, Inc. 14 Jun 2022 1 $0 4 Director 16 Jun 2022, 16:46
/report/000089924321023716-giordano-douglas-e-2021-06-10 Cerevel Therapeutics Holdings, Inc. 10 Jun 2021 1 $0 4 Director 14 Jun 2021, 20:04